MedTrace Logo

Different Doses of Sevoflurane During Induction of Anesthesia on Emergence Delirium in Children

NCT02707016 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2016-03-11

No results posted yet for this study

Summary

The investigators aim to reduce the incidence of emergence delirium in children aged 2-7 years old by using two different doses of sevoflurane during inhalatory induction of anesthesia.

Conditions

  • Delirium

Interventions

OTHER

Sevoflurane 8%

Sevoflurane 8% (high dose) during anesthesia induction

OTHER

Sevoflurane 5%

Sevoflurane 5% (low dose) during anesthesia induction

Sponsors & Collaborators

  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Nicolas Aeschlimann, MD · Assistant Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02707016 on ClinicalTrials.gov